Home
About
Overview
Sharing Data
ORCID
Help
History (22)
Occipital Bone
Tyrosine Kinase JAK2 and Myeloproliferative Disorders
Nursing, Supervisory
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
See All 22 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med. 2005 Nov 24; 353(21):2219-28.
View in:
PubMed
subject areas
Administration, Oral
Adult
Cross-Over Studies
Cyclophosphamide
Drug Therapy, Combination
Female
Glucocorticoids
Humans
Immunosuppressive Agents
Infusions, Intravenous
Lupus Nephritis
Male
Mycophenolic Acid
Prednisone
Remission Induction
Treatment Outcome
authors with profiles
Joan Merrill